According to the latest report by IMARC Group “Viscosupplementation Market: Global Industry Size, Price Trends, Share, Growth, Research Report, Opportunity and Forecast 2023-2028 “, The global viscosupplementation market size reached US$ 4.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$6.8 Billion by 2028, exhibiting a growth rate (CAGR) of 8.5% during 2023-2028. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form.
Viscosupplementation refers to a minimally invasive medical procedure wherein intraarticular injection comprising gel-like fluid called as exogenous hydraulic acid (HA) derivatives are directly administered into the knee joints of the patient. It acts as a lubricant, which enables bones to move smoothly over each other, lowers inflammation, and performs as a shock absorber for joint loads. Consequently, viscosupplementation is extensively used in the treatment of knee, hip, and hand osteoarthritis. It is mainly available in intermediate, low, and high molecular weights.
Request for a free sample copy of this report: https://www.imarcgroup.com/viscosupplementation-market/requestsample
Viscosupplementation Market Trends:
The growing prevalence of osteoporosis and osteoarthritis (OA) is primarily increasing the viscosupplementation market. Furthermore, the shifting consumer preferences toward minimally invasive non-surgical treatment options have facilitated the widespread adoption of the procedure in the healthcare sector for corticosteroids and joint pain management, which is positively influencing the global market. Apart from this, the increasing awareness among the masses regarding the numerous benefits of non-surgical treatments, including no hospitalization, fewer expenses, minimal complications, and better clinical outcomes and recovery rates, is acting as another significant growth-inducing factor. Moreover, the launch of favorable government initiatives and significant investments by several pharmaceutical companies to develop novel drugs and different routes of administration are also bolstering the market growth. Besides this, the emergence of ambulatory surgical centers (ACS) that offer intensive treatment to solve surgical and non-surgical problems in various body parts, such as joints, ligaments, muscles, spine, and nerves, is further catalyzing the global market. Additionally, the introduction of open-label single-injections with hydraulic acid is expected to drive the viscosupplementation market in the coming years. such as joints, ligaments, muscles, spine, and nerves, is further catalyzing the global market. Additionally, the introduction of open-label single-injections with hydraulic acid is expected to drive the viscosupplementation market in the coming years. such as joints, ligaments, muscles, spine, and nerves, is further catalyzing the global market. Additionally, the introduction of open-label single-injections with hydraulic acid is expected to drive the viscosupplementation market in the coming years.
Report Segmentation:
The report has segmented the market into the following categories:
Type Insights:
Single Injection
Three Injection
Five Injection
Age Group Insights:
Adults
Geriatrics
Distribution Channel Insights:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Application Insights:
Knee Osteoarthritis
Hip Osteoarthritis
Hand Osteoarthritis
Others
End Use Insights:
Hospitals
Orthopedic Clinics
Others
Market Breakup by Region:
North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa
Competitive Landscape:
Anika Therapeutics Inc., Aptissen SA
Bioventus LLC
Ferring Pharmaceuticals
Fidia Farmaceutici SpA
Johnson Johnson
LG Chem Ltd.
OrthogenRx Inc. (Avanos Medical Inc.)
Sanofi SA
Seikagaku Corporation
Virchow Biotech Private Limited
Zimmer Biomet
Zuventus HealthCare Ltd. (Emcure Pharmaceuticals Limited)
Ask Analyst for Customization and Browse full report with TOC List of Figure: https://www.imarcgroup.com/request?type=report&id=6931&flag=C
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers strategy management and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Website: https://www.imarcgroup.com/
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group
